322 related articles for article (PubMed ID: 26603570)
1. Cone-Specific Promoters for Gene Therapy of Achromatopsia and Other Retinal Diseases.
Ye GJ; Budzynski E; Sonnentag P; Nork TM; Sheibani N; Gurel Z; Boye SL; Peterson JJ; Boye SE; Hauswirth WW; Chulay JD
Hum Gene Ther; 2016 Jan; 27(1):72-82. PubMed ID: 26603570
[TBL] [Abstract][Full Text] [Related]
2. Targeting gene expression to cones with human cone opsin promoters in recombinant AAV.
Komáromy AM; Alexander JJ; Cooper AE; Chiodo VA; Glushakova LG; Acland GM; Hauswirth WW; Aguirre GD
Gene Ther; 2008 Jul; 15(14):1049-55. PubMed ID: 18337838
[TBL] [Abstract][Full Text] [Related]
3. Human blue-opsin promoter preferentially targets reporter gene expression to rat s-cone photoreceptors.
Glushakova LG; Timmers AM; Pang J; Teusner JT; Hauswirth WW
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3505-13. PubMed ID: 16877422
[TBL] [Abstract][Full Text] [Related]
4. Cone-specific expression using a human red opsin promoter in recombinant AAV.
Li Q; Timmers AM; Guy J; Pang J; Hauswirth WW
Vision Res; 2008 Feb; 48(3):332-8. PubMed ID: 17905404
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of AAV5 Vectors Expressing Human or Canine CNGB3 in CNGB3-Mutant Dogs.
Ye GJ; Komáromy AM; Zeiss C; Calcedo R; Harman CD; Koehl KL; Stewart GA; Iwabe S; Chiodo VA; Hauswirth WW; Aguirre GD; Chulay JD
Hum Gene Ther Clin Dev; 2017 Dec; 28(4):197-207. PubMed ID: 29020838
[TBL] [Abstract][Full Text] [Related]
6. Does recombinant adeno-associated virus-vectored proximal region of mouse rhodopsin promoter support only rod-type specific expression in vivo?
Glushakova LG; Timmers AM; Issa TM; Cortez NG; Pang J; Teusner JT; Hauswirth WW
Mol Vis; 2006 Apr; 12():298-309. PubMed ID: 16617297
[TBL] [Abstract][Full Text] [Related]
7. AAV-mediated expression targeting of rod and cone photoreceptors with a human rhodopsin kinase promoter.
Khani SC; Pawlyk BS; Bulgakov OV; Kasperek E; Young JE; Adamian M; Sun X; Smith AJ; Ali RR; Li T
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3954-61. PubMed ID: 17724172
[TBL] [Abstract][Full Text] [Related]
8. Identification of a zebrafish cone photoreceptor-specific promoter and genetic rescue of achromatopsia in the nof mutant.
Kennedy BN; Alvarez Y; Brockerhoff SE; Stearns GW; Sapetto-Rebow B; Taylor MR; Hurley JB
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):522-9. PubMed ID: 17251445
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy rescues cone function in congenital achromatopsia.
Komáromy AM; Alexander JJ; Rowlan JS; Garcia MM; Chiodo VA; Kaya A; Tanaka JC; Acland GM; Hauswirth WW; Aguirre GD
Hum Mol Genet; 2010 Jul; 19(13):2581-93. PubMed ID: 20378608
[TBL] [Abstract][Full Text] [Related]
10. Prospects for retinal cone-targeted gene therapy.
Alexander JJ; Hauswirth WW
Drug News Perspect; 2008 Jun; 21(5):267-71. PubMed ID: 18596991
[TBL] [Abstract][Full Text] [Related]
11. Vitreal delivery of AAV vectored Cnga3 restores cone function in CNGA3-/-/Nrl-/- mice, an all-cone model of CNGA3 achromatopsia.
Du W; Tao Y; Deng WT; Zhu P; Li J; Dai X; Zhang Y; Shi W; Liu X; Chiodo VA; Ding XQ; Zhao C; Michalakis S; Biel M; Zhang Z; Qu J; Hauswirth WW; Pang JJ
Hum Mol Genet; 2015 Jul; 24(13):3699-707. PubMed ID: 25855802
[TBL] [Abstract][Full Text] [Related]
12. Cone specific promoter for use in gene therapy of retinal degenerative diseases.
Dyka FM; Boye SL; Ryals RC; Chiodo VA; Boye SE; Hauswirth WW
Adv Exp Med Biol; 2014; 801():695-701. PubMed ID: 24664760
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy Evaluation of rAAV2tYF-PR1.7-hCNGA3 Vector Delivered by Subretinal Injection in CNGA3 Mutant Achromatopsia Sheep.
Gootwine E; Ofri R; Banin E; Obolensky A; Averbukh E; Ezra-Elia R; Ross M; Honig H; Rosov A; Yamin E; Ye GJ; Knop DR; Robinson PM; Chulay JD; Shearman MS
Hum Gene Ther Clin Dev; 2017 Jun; 28(2):96-107. PubMed ID: 28478700
[TBL] [Abstract][Full Text] [Related]
14. Gene Therapy in
Ma X; Sechrest ER; Fajardo D; Zhu P; Dyka F; Wang Y; Lobanova E; Boye SE; Baehr W; Deng WT
Hum Gene Ther; 2022 Jul; 33(13-14):708-718. PubMed ID: 35272502
[TBL] [Abstract][Full Text] [Related]
15. The human rhodopsin kinase promoter in an AAV5 vector confers rod- and cone-specific expression in the primate retina.
Boye SE; Alexander JJ; Boye SL; Witherspoon CD; Sandefer KJ; Conlon TJ; Erger K; Sun J; Ryals R; Chiodo VA; Clark ME; Girkin CA; Hauswirth WW; Gamlin PD
Hum Gene Ther; 2012 Oct; 23(10):1101-15. PubMed ID: 22845794
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Evaluation of AAV Vectors for Retinal Gene Therapy.
Wagner JE; Schön C; Becirovic E; Biel M; Michalakis S
Methods Mol Biol; 2019; 1834():383-390. PubMed ID: 30324456
[TBL] [Abstract][Full Text] [Related]
17. Long-term retinal cone rescue using a capsid mutant AAV8 vector in a mouse model of CNGA3-achromatopsia.
Dai X; He Y; Zhang H; Zhang Y; Liu Y; Wang M; Chen H; Pang JJ
PLoS One; 2017; 12(11):e0188032. PubMed ID: 29131863
[TBL] [Abstract][Full Text] [Related]
18. Six Years and Counting: Restoration of Photopic Retinal Function and Visual Behavior Following Gene Augmentation Therapy in a Sheep Model of
Ofri R; Averbukh E; Ezra-Elia R; Ross M; Honig H; Obolensky A; Rosov A; Hauswirth WW; Gootwine E; Banin E
Hum Gene Ther; 2018 Dec; 29(12):1376-1386. PubMed ID: 29926749
[TBL] [Abstract][Full Text] [Related]
19. Synthetic Adeno-Associated Viral Vector Efficiently Targets Mouse and Nonhuman Primate Retina In Vivo.
Carvalho LS; Xiao R; Wassmer SJ; Langsdorf A; Zinn E; Pacouret S; Shah S; Comander JI; Kim LA; Lim L; Vandenberghe LH
Hum Gene Ther; 2018 Jul; 29(7):771-784. PubMed ID: 29325457
[TBL] [Abstract][Full Text] [Related]
20. Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia.
Ye GJ; Budzynski E; Sonnentag P; Nork TM; Miller PE; McPherson L; Ver Hoeve JN; Smith LM; Arndt T; Mandapati S; Robinson PM; Calcedo R; Knop DR; Hauswirth WW; Chulay JD
Hum Gene Ther Clin Dev; 2016 Mar; 27(1):27-36. PubMed ID: 27003752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
